PMPeter B. F. Mensink

Peter B. F. Mensink

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peter B. F. Mensink has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Patients with chronic gastrointestinal ischemia have a higher cardiovascular disease risk and mortality

    by Aria Sana, Désirée van Noord, Peter B.F. Mensink, Stephanie Kooij, Kim van Dijk, Bert Bravenboer, Aloysius G. Lieverse, Eric J.G. Sijbrands, Janneke G. Langendonk, Ernst J. Kuipers


  • Response

    by Christopher W. Teshima, Huseyin Aktas, Peter B.F. Mensink

  • Single-balloon–assisted colonoscopy in patients with previously failed colonoscopy

    by Christopher W. Teshima, Huseyin Aktas, Jelle Haringsma, Ernst J. Kuipers, Peter B.F. Mensink


  • Endoscopic therapy of small-bowel polyps by double-balloon enteroscopy in patients with Peutz-Jeghers syndrome

    by Hong Gao, Margot G. van Lier, Jan Werner Poley, Ernst J. Kuipers, Monique E. van Leerdam, Peter B. Mensink


  • Impact of double-balloon enteroscopy findings on the management of Crohn's disease

    by Peter B. F. Mensink, Huseyin Aktas, Zuzana Zelinkova, Rachel L. West, Ernst J. Kuipers, Christien J. van der Woude

    Objective. It is estimated that 10%–30% of Crohn's disease (CD) patients have small-bowel lesions, but the exact frequency and clinical relevance of these findings are unknown. Double-balloon enteroscopy (DBE) enables endoscopic visualization of the small bowel. The aim of this study was to evaluate the use of DBE for detecting small-bowel lesions in CD patients suspected of having small-bowel involvement. Furthermore, the clinical impact of adjusting treatment in these patients was assessed. Material and methods. A prospective study was performed in a tertiary referral center. CD patients suspected of small-bowel involvement and in whom distal activity had previously been excluded were included. All patients underwent DBE, followed by step-up therapy in patients with small-bowel lesions. The presence of small-bowel lesions during DBE was noted and clinical outcome was assessed after adjusting therapy. Results. Thirty-five patients (70%) showed small-bowel lesions; these lesions could not be assessed by conventional endoscopy in 23 (46%). At 1-year follow-up, step-up therapy in 26 patients (74%) led to clinical remission in 23 (88%). This was confirmed by a significant decrease in Crohn's disease activity index and mucosal repair on second DBE. Conclusions. DBE showed a high frequency of small-bowel lesions in known CD patients with clinically suspected small-bowel activity. Most of these lesions were not accessible for conventional endoscopy. Adjusting treatment in patients with small-bowel CD involvement led to clinical remission and mucosal repair in the majority of cases.


  • Double-balloon enteroscopy in Crohn’s disease patients suspected of small bowel activity: findings and clinical impact

    by P. B. F. Mensink, M. J. Groenen, H. R. van Buuren, E. J. Kuipers, C. J. van der Woude

    It is estimated that 10–30% of patients with Crohn’s disease (CD) have small bowel (SB) involvement, but the exact frequency and clinical relevance of these findings is unknown. Double-balloon enteroscopy (DBE) enables endoscopic visualization of the SB. In this study we evaluated whether DBE is a feasible technique for detection of CD localized in the SB in CD patients with clinical suspicion of SB lesions and whether these findings have clinical impact. Retrospectively we analyzed 52 DBE procedures in 40 CD patients (16 males, mean age 40 years, mean duration of CD 15 years). Included patients had clinical suspicion of small bowel CD activity, including persistent abdominal discomfort (n = 27), iron deficiency anemia (n = 9) and/or hypomagnesemia (n = 4). Active small bowel CD was found in 24 (60%) patients, leading to a change in therapy in 18 patients (75%). After a mean follow-up of 13 months, 15 (83%) had persistent clinical improvement with a significant drop of mean CDAI from 178 to 90, after a mean follow-up of 13 months. DBE is a useful diagnostic tool for the evaluation of SB lesions in CD patients. The significance of these findings is emphasized by the fact that adjustment of therapy in the majority of these patients leads to significant and sustained clinical improvement.


  • Transient postprandial ischemia is associated with increased intestinal fatty acid binding protein in patients with chronic gastrointestinal ischemia

    by Peter B.F. Mensink, Lieke Hol, Nicole Borghuis-Koertshuis, Robert H. Geelkerken, Ard B. Huisman, Cees J.A. Doelman, Adriana J. van Vuuren, Ernst J. Kuipers, Jeroen J. Kolkman

    Chronic gastrointestinal ischemia (CGI) is still a difficult diagnosis to make. Currently, the only diagnostic with an acceptable sensitivity for actual mucosal ischemia is gastrointestinal tonometry. However, tonometry is a cumbersome and invasive diagnostic test. We are in need of a more simple, noninvasive test for diagnosing mucosal ischemia. A sensitive and early serum marker could be of great use in this setting. The aim of this study was to evaluate the use of promising serum markers for mucosal ischemia [intestinal fatty acid binding protein (I-FABP), D-lactate, and lipopolysaccharide] and compared findings with corresponding gastrointestinal tonometry measurements. Patients referred for evaluation of CGI were included. All patients had visualization of abdominal arteries and gastrointestinal tonometry. Before, during, and after tonometry blood samples were drawn for measurements of serum markers. Forty-nine patients were eligible for evaluation. CGI was diagnosed in 24 (49%) patients. The baseline measurements showed a significant increase in I-FABP before exercise tonometry in the abnormal-response groups compared with the normal-response group, respectively, 0.45 and 1.3 μg/l (P=0.04). An abnormal response on meal tonometry was associated with increased I-FABP levels, 1, 2, and 4 h after tonometry, compared with the patients with a normal response, respectively, 1.26, 1.11, and 0.58 μg/l (P=0.048, 0.01, and 0.03). The measurements of D-lactate and lipopolysaccharide were undetectable, or low, at all different points of time. Transient postprandial mucosal ischemia, as detected with gastrointestinal tonometry, is associated with increased I-FABP levels, indicating epithelial damage. Late markers for mucosal ischemia remained negative.


    • 22 September 2007
      • Vol. 151  (38) , 2087-93

    [Double-balloon enteroscopy of the small intestine].

    by P B F Mensink, E J Kuipers

    Since the introduction of double-balloon enteroscopy (DBE), the small intestine has come into easy reach for endoscopy. By the 'push and pull' technique, the endoscope can be introduced far into the small intestine. Diagnostic endoscopy can be combined with endoscopic treatment in the small intestine, for example in patients with intestinal bleeding (angiodysplasia), polyps, tumours, or stenosis of the small intestine. DBE is especially important for patients with gastrointestinal blood loss that cannot be explained by the results of gastroscopy and colonoscopy. The added value of DBE in patients with other possible diseases of the small intestine, such as refractory coeliac disease or Crohn's disease, seems certain and is currently under investigation. In patients with Crohn's disease, endoscopic dilation of strictures may eliminate the need for surgical intervention. DBE can be performed on an outpatient basis. The complication rate of diagnostic DBE seems low, but in therapeutic sessions the complication rate is higher than for therapeutic colonoscopy.


  • Open Access

    Twenty-Four Hour Tonometry in Patients Suspected of Chronic Gastrointestinal Ischemia

    by Peter B. F. Mensink, Robert H. Geelkerken, Ad B. Huisman, Ernst J. Kuipers, Jeroen J. Kolkman

    Gastrointestinal tonometry is currently the only clinical diagnostic test that enables identification of symptomatic chronic gastrointestinal ischemia. Gastric exercise tonometry has proven its value for detection of ischemia in this patients group, but has its disadvantages. Earlier studies with postprandial tonometry gave unreliable results. In this study we challenged (again) the use of postprandial tonometry in patients suspected of gastrointestinal ischemia.


  • Complications of double balloon enteroscopy: a multicenter survey

    by P. Mensink, J. Haringsma, T. Kucharzik, C. Cellier, E. Pérez-Cuadrado, K. Mönkemüller, A. Gasbarrini, A. Kaffes, K. Nakamura, H. Yen, et al.

    Background and study aims: Double balloon enteroscopy (DBE) is a new technique for the visualization of the small bowel. Although the technique is widely used, little is known about the complications. A few complications have been reported in the literature, mainly in case reports. The aim of this study was to establish the complication rate of both diagnostic and therapeutic DBE. Patients and methods: A total of 10 centers (nine academic centers and one teaching hospital) across four continents participated in the study. Complications were defined according to the literature. A therapeutic DBE was defined as a DBE with use of argon plasma coagulation, a polypectomy snare, injection of fluids (other than ink for marking), removal of foreign body, or balloon dilation. Results: A total 85 adverse events were reported in 2362 DBE procedures. In all, 40 events fulfilled the definition of a complication, 13 in 1728 diagnostic DBE (0.8 %) and 27 during 634 therapeutic procedures (4.3 %). The complications were rated minor in 21 (0.9 %), moderate in 6 (0.3 %) and severe in 13 procedures (0.6 %). No fatal complications were reported. Seven cases of pancreatitis were reported, six after diagnostic (0.3 %) and one after therapeutic (0.2 %) DBE. Conclusions: Diagnostic DBE is safe with a low complication rate. The complication rate of therapeutic DBE is high compared with therapeutic colonoscopy. The reason for this is unclear. The incidence of pancreatitis after DBE is low (0.3 %), but has to be considered in patients with persistent abdominal complaints after a DBE procedure.